BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29903021)

  • 1. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer.
    Friedrich M; Nowe E; Hofmeister D; Kuhnt S; Leuteritz K; Sender A; Stöbel-Richter Y; Geue K
    Health Qual Life Outcomes; 2018 Jun; 16(1):125. PubMed ID: 29903021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
    Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
    Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
    J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in the general population: German normative values of the EORTC QLQ-FA12.
    Hinz A; Weis J; Brähler E; Mehnert A
    Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation.
    Weis J; Wirtz MA; Tomaszewski KA; Hammerlid E; Arraras JI; Conroy T; Lanceley A; Schmidt H; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Harle A; Flechtner HH; Bottomley A;
    Psychooncology; 2019 Aug; 28(8):1753-1761. PubMed ID: 31225669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
    Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
    Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13.
    Fuhrmann K; Mehnert A; Geue K; Hinz A
    Breast Cancer; 2015 Nov; 22(6):608-14. PubMed ID: 24633470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
    Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: a cross-sectional pragmatic study.
    Strasser F; Müller-Käser I; Dietrich D
    J Pain Symptom Manage; 2009 Oct; 38(4):505-14. PubMed ID: 19822275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
    Serrano D; Podger L; Barnes G; Song J; Tang B
    Qual Life Res; 2022 Mar; 31(3):937-950. PubMed ID: 34518988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
    Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A
    Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
    Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
    Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
    O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
    Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cultural adaptation and psychometric validation of the health-related quality of life questionnaire EORTC QLQ STO-22 for patients with gastric cancer in Peru].
    Soria Moncada JM; Carrasco Lozano JG; Loza Munarriz C; Ruiz Figueroa E; Payet Meza E
    Rev Gastroenterol Peru; 2015; 35(2):127-35. PubMed ID: 26228978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring fatigue in cancer patients: a common metric for six fatigue instruments.
    Friedrich M; Hinz A; Kuhnt S; Schulte T; Rose M; Fischer F
    Qual Life Res; 2019 Jun; 28(6):1615-1626. PubMed ID: 30815769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.